These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 9556902

  • 1. [Bioavailability of 17 beta-estradiol after transdermal administration--dependence on the patch system].
    Schmolling J, Kusche J, van der Ven H, Schander K.
    Zentralbl Gynakol; 1998; 120(3):121-5. PubMed ID: 9556902
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of estradiol and of estrone during application of a new 7-day estradiol transdermal patch with active matrix.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1998 Mar; 48(3):275-85. PubMed ID: 9553686
    [Abstract] [Full Text] [Related]

  • 3. Plasma profiles of transdermal 17 beta-estradiol delivered by two different matrix patches. A four-way cross-over study in postmenopausal women.
    Rohr UD, Ehrly AM, Kuhl H.
    Arzneimittelforschung; 1997 Jun; 47(6):761-7. PubMed ID: 9239456
    [Abstract] [Full Text] [Related]

  • 4. Bioavailability of estradiol from two transdermal patches.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1996 Mar; 46(3):307-10. PubMed ID: 8901155
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1996 Aug; 46(8):766-73. PubMed ID: 9125276
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol.
    Scott RT, Ross B, Anderson C, Archer DF.
    Obstet Gynecol; 1991 May; 77(5):758-64. PubMed ID: 2014092
    [Abstract] [Full Text] [Related]

  • 7. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P, Ozel B, Stanczyk FZ, Felix JC, Mishell DR.
    Menopause; 2008 May; 15(1):94-7. PubMed ID: 17882008
    [Abstract] [Full Text] [Related]

  • 8. [Kinetics of a new patch for transdermal administration of 17 beta-estradiol].
    Rohr UD, Nauert C, Ehrly AM.
    Zentralbl Gynakol; 1995 May; 117(10):531-9. PubMed ID: 7491836
    [Abstract] [Full Text] [Related]

  • 9. Gonadotropin dynamics in women receiving immediate or delayed transdermal estradiol after oophorectomy.
    Kamel EM, Maurer SA, Hochler MG, Hoffman DI, Rebar RW.
    Obstet Gynecol; 1991 Jul; 78(1):98-102. PubMed ID: 1904568
    [Abstract] [Full Text] [Related]

  • 10. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 11. Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies.
    Rovati LC, Schmid K, Giacovelli G, Bonn M, Setnikar I, Wolff F, Genazzani AR.
    Arzneimittelforschung; 1999 Nov; 49(11):933-43. PubMed ID: 10604047
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of weekly transdermal estradiol controlled delivery system in postmenopausal Chinese.
    Chen GS, Zhang MY, Wang Q, Ye JC.
    Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):407-10. PubMed ID: 9863160
    [Abstract] [Full Text] [Related]

  • 13. Estradiol and estrone plasma levels during application of three strengths of a 7-day estradiol transdermal patch.
    Setnikar I, Rovati LC, Santoro A, Guillaume M, Mignot A, Renoux A, Gualano V.
    Arzneimittelforschung; 1999 Aug; 49(8):708-15. PubMed ID: 10483519
    [Abstract] [Full Text] [Related]

  • 14. Characterization of a 7 day 17 beta-estradiol transdermal delivery system: pharmacokinetics in healthy postmenopausal women.
    Boyd RA, Zegarac EA, Eldon MA, Sedman AJ, Forgue ST.
    Biopharm Drug Dispos; 1996 Aug; 17(6):459-70. PubMed ID: 8866037
    [Abstract] [Full Text] [Related]

  • 15. 17Beta-estradiol delivered by three different matrix patches 50 microg/day: a three way cross-over study in 21 postmenopausal women.
    Rohr UD, Nauert C, Stehle B.
    Maturitas; 1999 Sep 24; 33(1):45-58. PubMed ID: 10585173
    [Abstract] [Full Text] [Related]

  • 16. Steady-state bioavailability of estradiol from two matrix transdermal delivery systems, Alora and Climara.
    Buch A, Shen L, Kelly S, Sahota R, Brezovic C, Bixler C, Powell J.
    Menopause; 1998 Sep 24; 5(2):107-12. PubMed ID: 9689205
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of estradiol and of estrone during application of three strengths of an estradiol transdermal patch with active matrix.
    Setnikar I, Rovati LC, Thebault JJ, Guillaume M, Mignot A, Renoux A, Gualano V.
    Arzneimittelforschung; 1997 Jul 24; 47(7):859-65. PubMed ID: 9272245
    [Abstract] [Full Text] [Related]

  • 18. The effect of transdermal estradiol on hormone and metabolic dynamics over a six-week period.
    Haas S, Walsh B, Evans S, Krache M, Ravnikar V, Schiff I.
    Obstet Gynecol; 1988 May 24; 71(5):671-6. PubMed ID: 3357653
    [Abstract] [Full Text] [Related]

  • 19. Efficacy on climacteric symptoms and safety of low dose estradiol transdermal matrix patches. A randomized, double-blind placebo-controlled study.
    De Aloysio D, Rovati LC, Giacovelli G, Setnikar I, Bottiglioni F.
    Arzneimittelforschung; 2000 Mar 24; 50(3):293-300. PubMed ID: 10758784
    [Abstract] [Full Text] [Related]

  • 20. Estradiol pharmacokinetics after transdermal application of patches to postmenopausal women: matrix versus reservoir patches.
    Reginster JY, Donazzolo Y, Brion N, Lins R.
    Climacteric; 2000 Sep 24; 3(3):168-75. PubMed ID: 11910618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.